Relox Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 29-12-2024
- Paid Up Capital ₹ 0.16 M
as on 29-12-2024
- Company Age 9 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 71.30%
(FY 2020)
- Profit 127.30%
(FY 2020)
- Ebitda 138.42%
(FY 2020)
- Net Worth 13.14%
(FY 2020)
- Total Assets 49.72%
(FY 2020)
About Relox Diagnostics
The Corporate was formerly known as Path Virtual Lab Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.16 M, as per Ministry of Corporate Affairs (MCA) records.
Alap Adeshara, Paresh Jhurmarwala, Maulin Patel, and One other member serve as directors at the Company.
- CIN/LLPIN
U85195GJ2015PTC084892
- Company No.
084892
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Oct 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Relox Diagnostics Private Limited offer?
Relox Diagnostics Private Limited offers a wide range of products and services, including Diagnostic Imaging & Pathology Labs, Medical Test Services, Computer Software & Mobile Apps, Laboratory Management Software, Computer and Mobile Softwares & Apps.
Who are the key members and board of directors at Relox Diagnostics?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Paresh Jhurmarwala  | Director | 28-Oct-2015 | Current |
| Alap Adeshara | Director | 30-Jun-2017 | Current |
| Maulin Patel | Director | 20-Jun-2018 | Current |
| Adit Desai | Nominee Director | 30-Sep-2021 | Current |
Financial Performance of Relox Diagnostics.
Relox Diagnostics Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 71.3% increase. The company also saw a substantial improvement in profitability, with a 127.3% increase in profit. The company's net worth Soared by an impressive increase of 13.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Relox Diagnostics?
In 2020, Relox Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pharmace Research Laboratory Private LimitedActive 1 year 6 monthsParesh Jhurmarwala is a mutual person
Viva Events Management Private LimitedActive 14 years 8 monthsParesh Jhurmarwala is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Relox Diagnostics?
Unlock and access historical data on people associated with Relox Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Relox Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Relox Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
